Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H30O2 |
Molecular Weight | 302.451 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@]3([H])[C@@]4([H])CCC(=O)C=C4C[C@@H](C)[C@@]23[H]
InChI
InChIKey=PTQMMNYJKCSPET-OMHQDGTGSA-N
InChI=1S/C20H30O2/c1-12-10-13-11-14(21)4-5-15(13)16-6-8-19(2)17(18(12)16)7-9-20(19,3)22/h11-12,15-18,22H,4-10H2,1-3H3/t12-,15+,16-,17+,18-,19+,20+/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2422638Curator's Comment: Description was created based on several sources, including
http://www.skylocke.com/pdf_txt/CHEQUE-Drops.PDF | https://www.ncbi.nlm.nih.gov/pubmed/18515094 | https://anabolic.org/cheque-drops-mibolerone/
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2422638
Curator's Comment: Description was created based on several sources, including
http://www.skylocke.com/pdf_txt/CHEQUE-Drops.PDF | https://www.ncbi.nlm.nih.gov/pubmed/18515094 | https://anabolic.org/cheque-drops-mibolerone/
Mibolerone is a synthetic anabolic steroid. It binds both androgen and progesterone receptors and exerts both androgenic and progestagenic actions.
Mibolerone (CHEQUE® Drops) was used in veterinary for estrous (heat) prevention in adult female dogs not intended primarily for breeding purposes. No prescription preparation, human or veterinary, is currently known to contain mibolerone worldwide.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Activation of androgen receptor in epidermal growth factor modulation of fetal mouse sexual differentiation. | 1996 Oct 14 |
|
Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptor. | 2001 Jul |
|
Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome. | 2001 Jun |
|
Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP. | 2001 Sep |
|
Forced expression of heat-shock protein 70 increases the secretion of Hsp70 and provides protection against tumour growth. | 2004 Feb 23 |
|
Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter. | 2004 Mar |
|
[Regulation of expression of pituitary tumor transforming gene 1 (PTTG1) by androgen in prostate cancer]. | 2005 Dec 18 |
|
COMPRENDO: Focus and approach. | 2006 Apr |
|
Collision-induced dissociation pathways of anabolic steroids by electrospray ionization tandem mass spectrometry. | 2006 Apr |
|
Expression and function of the human androgen-responsive gene ADI1 in prostate cancer. | 2007 Aug |
|
Steroids with a carbamate function at C-17, a novel class of inhibitors for human and hamster steroid 5alpha-reductase. | 2007 Oct |
|
Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents. | 2007 Sep |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.skylocke.com/pdf_txt/CHEQUE-Drops.PDF
CHEQUE® DROPS mibolerone 100 ug/ml
female dogs: 1 to 25 lbs - 30 ug, 26 to 50 lbs - 60 ug, 51 to 100 lbs - 120 ug, 101 and over lbs - 180 ug orally once each day by adding to a small amount of food or directly to the mouth
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18515094
Whereas high physiological doses (10-100nM) of 5alpha-dihydrotestosterone reduced E(2)-mediated induction of the estrogen-regulated gene progesterone receptor (PR) to basal levels, mibolerone at lower doses (1nM) eliminated PR expression, suggesting that mibolerone may also act via the PR.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C243
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
||
|
CFR |
21 CFR 520.1430
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
||
|
WIKIPEDIA |
Designer-drugs-Mibolerone
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
||
|
DEA NO. |
4000
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
||
|
CFR |
21 CFR 558.348
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB08941MIG
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
3203
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
251636
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
DB11429
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
C100075
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
CHEMBL425863
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
72260
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
3704-09-4
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
34849
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
DTXSID4036489
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
1443362
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
C72100
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
223-046-5
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
9OGY4BOR8D
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
MIBOLERONE
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | |||
|
M7523
Created by
admin on Sun Dec 18 17:55:31 UTC 2022 , Edited by admin on Sun Dec 18 17:55:31 UTC 2022
|
PRIMARY | Merck Index |
ACTIVE MOIETY